Terrabio
Developer of a compact, field-deployable molecular diagnostics platform for nucleic-acid detection. The platform supports real-time qPCR, conventional PCR and LAMP workflows with integrated DNA isolation, multiplexed detection and a claimed time-to-result under 90 minutes. Primary application domains described are agriculture, food and water safety, veterinary diagnostics and laboratory screening. The organisation performs assay design and optimisation, hardware and embedded software development, and has completed engineering/EMC evaluations.
Industries
Nr. of Employees
small (1-50)
Terrabio
Duńska 7, building OMEGA, 54-427 Wrocław, Poland
Patents
Products
Portable rtPCR molecular analyzer (compact platform)
Compact molecular diagnostics platform that integrates DNA isolation, nucleic-acid amplification (qPCR/PCR/LAMP), multiplexed detection and automated result interpretation for on-site testing.
Portable rtPCR molecular analyzer (compact platform)
Compact molecular diagnostics platform that integrates DNA isolation, nucleic-acid amplification (qPCR/PCR/LAMP), multiplexed detection and automated result interpretation for on-site testing.
Services
Design and full optimisation of qPCR assays tailored to customer needs in agriculture, food, water and veterinary sectors; delivery of ready-to-use assays.
Support for implementing the portable diagnostic platform at customer sites, including device delivery and onboarding.
Design and full optimisation of qPCR assays tailored to customer needs in agriculture, food, water and veterinary sectors; delivery of ready-to-use assays.
Support for implementing the portable diagnostic platform at customer sites, including device delivery and onboarding.
Expertise Areas
- Molecular diagnostics (qPCR/PCR/LAMP)
- Field-deployable/point-of-collection testing
- qPCR assay design and optimisation
- Food and water safety testing
Key Technologies
- Real-time quantitative PCR (qPCR)
- Conventional PCR
- LAMP (loop-mediated isothermal amplification)
- Multiplex fluorescence detection
News & Updates
Selected for the final of the EEC Startup Challenge and presented the compact rtPCR platform at the European Economic Congress; final presentation held on May 8, 2024.
Device engineering tests completed in preparation for electromagnetic compatibility evaluation; platform described as meeting EMC requirements and immune to interference.
Selected to the next stage of the EEC Startup Challenge and listed among top startups invited to present at the European Economic Congress.
Presentation and discussion of integrating molecular diagnostics results with AI-driven tools for diagnosis and treatment support in swine health management.
Engineering tests completed in preparation for EMC evaluation; step reported toward commercialization of the screening system.
Company reached the final of the EEC Startup Challenge and presented at the European Economic Congress.
Selected for the final of the EEC Startup Challenge and presented the compact rtPCR platform at the European Economic Congress; final presentation held on May 8, 2024.
Device engineering tests completed in preparation for electromagnetic compatibility evaluation; platform described as meeting EMC requirements and immune to interference.
Selected to the next stage of the EEC Startup Challenge and listed among top startups invited to present at the European Economic Congress.
Presentation and discussion of integrating molecular diagnostics results with AI-driven tools for diagnosis and treatment support in swine health management.
Engineering tests completed in preparation for EMC evaluation; step reported toward commercialization of the screening system.
Company reached the final of the EEC Startup Challenge and presented at the European Economic Congress.